MUC16 and neoplasm: Recurrence may be suspected on clinical grounds or based on rising tumor markers such as cancer embryonic antigen (CEA), cancer antigen 15-3 (CA 15-3) and less commonly cancer antigen 19-9 (CA19-9) and cancer antigen 125 (CA125) [76].